Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Chizzolini

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|October 19, 2018
Autoantibodies Against Albumin in Patients With Systemic Lupus ErythematosusJosephine Nehring, Lucia A Schirmbeck, Justa Friebus-Kardash, et al.
BMC Immunology|March 30, 2017
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)Benjamin Chaigne, Carlo Chizzolini, Thomas Perneger, et al.
Revue Medicale Suisse|May 16, 2009
[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]Carlo Chizzolini, Clemens D Cohen, Ute Eisenberger, et al.
Frontiers in Immunology|December 3, 2019
Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic SiteKinga Csorba, Lucia A Schirmbeck, Eylul Tuncer, et al.
The Israel Medical Association Journal : IMAJ|November 29, 2002
Anti-fibroblast antibodies in systemic sclerosisNicoletta Ronda, Elena Raschi, Cinzia Testoni, et al.
Rheumatology (Oxford, England)|February 18, 2011
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesionsTommaso Lombardi, Solange Moll, Pierre Youinou, et al.
Arthritis and Rheumatism|January 22, 2013
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvementMarie-Elise Truchetet, Nicolò-Costantino Brembilla, Elisa Montanari, et al.
European Journal of Immunology|August 14, 2010
Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cellsJean-Marie Ramirez, Nicolò C Brembilla, Olivier Sorg, et al.
Journal of the American Academy of Dermatology|July 15, 2019
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literatureHélène Traineau, Rohit Aggarwal, Jean-Benoît Monfort, et al.
Journal of Translational Autoimmunity|October 24, 2024
Extrafollicular CD19<sup>low</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosusCarlo Chizzolini, Jean-Charles Guery, Fanny Noulet, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|October 19, 2018
Autoantibodies Against Albumin in Patients With Systemic Lupus ErythematosusJosephine Nehring, Lucia A Schirmbeck, Justa Friebus-Kardash, et al.
BMC Immunology|March 30, 2017
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)Benjamin Chaigne, Carlo Chizzolini, Thomas Perneger, et al.
Revue Medicale Suisse|May 16, 2009
[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]Carlo Chizzolini, Clemens D Cohen, Ute Eisenberger, et al.
Frontiers in Immunology|December 3, 2019
Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic SiteKinga Csorba, Lucia A Schirmbeck, Eylul Tuncer, et al.
The Israel Medical Association Journal : IMAJ|November 29, 2002
Anti-fibroblast antibodies in systemic sclerosisNicoletta Ronda, Elena Raschi, Cinzia Testoni, et al.
Rheumatology (Oxford, England)|February 18, 2011
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesionsTommaso Lombardi, Solange Moll, Pierre Youinou, et al.
Arthritis and Rheumatism|January 22, 2013
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvementMarie-Elise Truchetet, Nicolò-Costantino Brembilla, Elisa Montanari, et al.
European Journal of Immunology|August 14, 2010
Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cellsJean-Marie Ramirez, Nicolò C Brembilla, Olivier Sorg, et al.
Journal of the American Academy of Dermatology|July 15, 2019
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literatureHélène Traineau, Rohit Aggarwal, Jean-Benoît Monfort, et al.
Journal of Translational Autoimmunity|October 24, 2024
Extrafollicular CD19<sup>low</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosusCarlo Chizzolini, Jean-Charles Guery, Fanny Noulet, et al.
Pageof 11